Publications

Results 1–25 of 68

Search results

Jump to search filters

Labauve, A.E., Saada, E.A., Jones, I.K.A., Mosesso, R., Noureddine, A., Techel, J., Gomez, A., Collette, N., Sherman, M.B., Serda, R.E., Butler, K.S., Brinker, C.J., Schoeniger, J.S., Sasaki, D., Negrete, O.A., & Negrete, O.A. (2023). Lipid-coated mesoporous silica nanoparticles for anti-viral applications via delivery of CRISPR-Cas9 ribonucleoproteins. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-33092-4

Schwedler, J., Sumner, C.A., Lopez-Cazares, G., Sinha, A., McIlroy, P.R., Light, Y.K., Welborn, D.G., Negrete, O.A., Harmon, B.N., & Harmon, B.N. (2023). A pipeline for discovery & applications for Brain-targeting nanoparticle drug delivery & Engineered therapeutics [Poster]. 10.2172/2431119

Sumner, C.A., Schwedler, J., Stefan, M., Sinha, A., McIlroy, P.R., Light, Y.K., Thatcher, C.E., Kim, C.Y., Weilhammer, D.R., Negrete, O.A., Harmon, B.N., & Harmon, B.N. (2022). Characterization of novel BBB-penetrating nanobodies for delivery of therapeutic cargo to the CNS [Conference Poster]. 10.2172/2588934

Choudhary, H., Lopez-Cazares, G., Branda, S., Negrete, O.A., & Negrete, O.A. (2022). Lipid-Coated Mesoporous Silica Nanoparticles for Targeted Drug Delivery Across the Blood-Brain Barrier [Conference Poster]. 10.2172/2432100

Sumner, C.A., Schwedler, J., Stefan, M., Sinha, A., McIlroy, P.R., Thatcher, C., Kim, C.Y., Weilhammer, D.R., Negrete, O.A., Harmon, B.N., & Harmon, B.N. (2022). Characterization of SNL identified BBB-penetrating moieties (BBB PMs) for delivery of therapeutic cargo to the CNS [Conference Poster]. 10.2172/2006120

Jones, I.K.A., Lund, S., Collette, N., Sinha, A., Light, Y.K., Negrete, O.A., & Negrete, O.A. (2022). CRISPR pooled library screens offer an effective tool for identifying therapeutic targets against broad viral families [Conference Poster]. 10.2172/2005946

Lund, S., Collette, N., Sinha, A., Welborn, D.G., Mosesso, R., Schwedler, J., Schoeniger, J.S., Negrete, O.A., & Negrete, O.A. (2022). Imaging and Efficacy of in vivo Lipid Nanoparticle Delivery in Genome Editing [Conference Poster]. 10.2172/2003928

Lund, S., Collete, N., Sinha, A., Welborn, D.G., Mosesso, R., Schwedler, J., Schoeniger, J.S., Negrete, O.A., & Negrete, O.A. (2022). Imaging in vivo Lipid Nanoparticle Delivery [Conference Poster]. 10.2172/2003836

Collette, N., Dhungel, P., Lund, S., Schwedler, J., Freiberg, A., Schoeniger, J.S., Negrete, O.A., & Negrete, O.A. (2022). NSVconferencePoster.ONegrete [Conference Poster]. 10.2172/2003487

Collette, N., Dhungel, P., Lund, S., Schwedler, J., Saada, E.A., Sinha, A., Light, Y.K., Schoeniger, J.S., Negrete, O.A., & Negrete, O.A. (2021). Immunocompromised Cas9 transgenic mice for rapid in vivo assessment of host factors involved in highly pathogenic virus infection. Molecular Therapy Methods and Clinical Development, 23, pp. 286-295. https://doi.org/10.1016/j.omtm.2021.09.012

Mosesso, R., Courtney, C.M., Collette, N., Negrete, O.A., Schoeniger, J.S., & Schoeniger, J.S. (2021). Controlling CRISPR via RNA Delivery using Lipid Nanoparticles [Conference Poster]. 10.2172/1866909

Negrete, O.A., Bradfute, S., Larson, S.R., Sinha, A., Coombes, K.R., Goeke, R.S., Keenan, L.A., Duay, J., van Heukelom, M., Meserole, S., Jacobs-Gedrim, R.B., & Jacobs-Gedrim, R.B. (2020). Photocatalytic Material Surfaces for SARS-CoV-2 Virus Inactivation. 10.2172/1669200

Rossman, G.A., Avina, I.C., Steinfeldt, B., Koplow, J., Smith, K., Jouravel, N., Buffleben, G.M., Sinha, A., Negrete, O.A., Barnett, T., Karnesky, R.A., Melia, M.A., Taylor, J.M., Sorensen, N.R., Ackermann, M.R., Bachand, G.D., Harmon, B.N., Jones, B.H., Miller, P.R., … Foulk, J.W. (2020). Sandia's Research in Support of COVID-19 Pandemic Response: Materials Science. 10.2172/1681092

Koplow, J., Smith, K., Jouravel, N., Buffleben, G.M., Sinha, A., Negrete, O.A., Barnett, T., Karnesky, R.A., & Karnesky, R.A. (2020). Supercritical CO2 sterilization of N95 Masks. 10.2172/1821584

Labauve, A.E., Rinker, T., Noureddine, A., Sasaki, D., Rasley, A., Brinker, J., Negrete, O.A., & Negrete, O.A. (2019). Lipid-Coated Mesoporous Silica Nanoparticle Technology for Antiviral Delivery to Inhibit Encephalitic Alphavirus Infection [Conference Poster]. https://www.osti.gov/biblio/1640950

Courtney, C.M., Johnston, R.K., Labauve, A.E., Collete, N., Edwin, S.A., Negrete, O.A., Branda, S., Butler, K.S., Schoeniger, J.S., & Schoeniger, J.S. (2019). Nanoparticle Delivery Platforms for Controlled Inhibition of CRISPR Gene Editing [Presentation]. https://www.osti.gov/biblio/1648796

Labauve, A.E., Rinker, T.E., Noureddine, A., Serda, R.E., Howe, J.Y., Sherman, M.B., Rasley, A., Brinker, C.J., Sasaki, D.Y., Negrete, O.A., & Negrete, O.A. (2018). Lipid-Coated Mesoporous Silica Nanoparticles for the Delivery of the ML336 Antiviral to Inhibit Encephalitic Alphavirus Infection. Scientific Reports, 8(1). https://doi.org/10.1038/s41598-018-32033-w

Labauve, A.E., Sasaki, D.Y., Brinker, C.J., Negrete, O.A., Rinker, T., Noureddine, A., Rasley, A., & Rasley, A. (2018). Lipid-Coated Mesoporous Silica Nanoparticle Technology for Antiviral Delivery to Inhibit Encephalitic Alphavirus Infection [Presentation]. https://www.osti.gov/biblio/1594317

Negrete, O.A., Saada, E.A., Strutt, S., Brinker, C.J., Foulk, J.W., Schoeniger, J.S., & Schoeniger, J.S. (2018). Development and Delivery of Safe CRISPR-based Anti-Viral Countermeasures Targeting Host and Viral Genomes [Conference Poster]. https://www.osti.gov/biblio/1806799

Results 1–25 of 68
Results 1–25 of 68